Objective To review evidence of existing and new pharmacological therapies for lowering
lipoprotein(a) (Lp[a]) concentrations and their impact on clinically relevant outcomes. Methods …

The role of SGLT-2 inhibitors in managing type 2 diabetes. - Abstract - Europe PMC Sign in |
Create an account https://orcid.org Europe PMC Menu About Tools Developers Help Contact …

Objective To determine the prevalence of obesity and assess the cardiometabolic risk profile
and treatments associated with obesity management in the type 1 diabetes mellitus adult …

Objective To review evidence of existing literature on the management of statin intolerance.
Methods We searched for literature pertaining to statin intolerance and treatments in PubMed…

Aims To investigate the prevalence and clinical risk factors for non-alcoholic fatty liver disease
(NAFLD) in type 1 diabetes (T1DM) by liver scores. Methods A retrospective, unicenter, …

Objective Brown tumors develop as skeletal manifestations of hyperparathyroidism. Increased
osteoclast activity leads to accumulation of highly active giant cells and to excess cortical …

The hypothalamic-pituitary-adrenal (HPA) axis and the hypothalamic-pituitary-gonadal (HPG)
axis are very sensitive and can be affected by external factors like stress, starvation, and …

Introduction Randomized clinical trials identified a small increased risk of acute pancreatitis
in patients using glucagon-like peptide-1 receptor agonist (GLP1- RA) therapy. As a result, …

Objective Glaucoma is a well-recognized side effect of corticosteroids. However, steroid-induced
glaucoma typically refers to that caused by exogenous corticosteroid administration. …

Objective A significant cause for adverse outcomes in hospitalized patients is hypoglycemia.
It is known to increase morbidity and mortality, lengthen hospital stay, and subsequently …